Brickell Biotech Stock Technical Analysis

BBI Stock  USD 0.91  0.01  1.11%   
As of the 19th of April, Brickell Biotech shows the Standard Deviation of 1.89, mean deviation of 1.22, and Risk Adjusted Performance of (0.02). Brickell Biotech technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed thirteen technical drivers for Brickell Biotech, which can be compared to its peers. Please confirm Brickell Biotech information ratio, as well as the relationship between the value at risk and kurtosis to decide if Brickell Biotech is priced correctly, providing market reflects its regular price of 0.91 per share. Given that Brickell Biotech is a hitting penny stock territory we recommend to closely look at its jensen alpha.

Brickell Biotech Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Brickell, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Brickell
  
Brickell Biotech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Brickell Biotech Analyst Consensus

Target PriceAdvice# of Analysts
5.0Strong Buy2Odds
Brickell Biotech current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Brickell analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Brickell stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Brickell Biotech, talking to its executives and customers, or listening to Brickell conference calls.
Brickell Analyst Advice Details
Brickell Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Brickell Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Brickell Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Brickell Biotech Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Brickell Biotech volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Brickell Biotech Trend Analysis

Use this graph to draw trend lines for Brickell Biotech. You can use it to identify possible trend reversals for Brickell Biotech as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Brickell Biotech price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Brickell Biotech Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Brickell Biotech applied against its price change over selected period. The best fit line has a slop of   0.0017  , which may imply that the returns on investment in Brickell Biotech will continue to fail. It has 122 observation points and a regression sum of squares at 0.11, which is the sum of squared deviations for the predicted Brickell Biotech price change compared to its average price change.

About Brickell Biotech Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Brickell Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Brickell Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Brickell Biotech price pattern first instead of the macroeconomic environment surrounding Brickell Biotech. By analyzing Brickell Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Brickell Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Brickell Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Days Sales Outstanding228.45239.87
PTB Ratio0.01890.0198

Brickell Biotech April 19, 2024 Technical Indicators

Most technical analysis of Brickell help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Brickell from various momentum indicators to cycle indicators. When you analyze Brickell charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether Brickell Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brickell Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brickell Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brickell Biotech Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.
Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech's price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Managers
Screen money managers from public funds and ETFs managed around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.42)
Revenue Per Share
1.94
Quarterly Revenue Growth
27.576
Return On Assets
(0.80)
Return On Equity
(1.57)
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brickell Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.